Emerging Genetic Mutation Associated with Drug Resistance in Non-Small Cell Lung Cancer Patients
A recent publication details a compelling case study revolving around a patient diagnosed with stage IV non-small cell lung cancer (NSCLC) characterized by a CD74-ROS1...